Drug · DIN 02216981
MRV
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 27, 2000; first marketed November 11, 1996.
- Drug Identification Number (DIN)
- 02216981
- Company (DIN owner)
- Hollister-Stier Laboratories LlcSpokane, Washington, United States
- Schedule
- Schedule D
- Dosage form
- Suspension
- Route
- Intradermal; Subcutaneous
- Therapeutic class (ATC)
- Other bacterial vaccines J07AX
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| STAPHYLOCOCCUS AUREUS | 1200 M | ML |
| STREPTOCOCCUS (VIRIDANS AND NON-HEMOLYTIC) | 200 M | ML |
| STREPTOCOCCUS (DIPLOCOCCUS) PNEUMONIAE | 150 M | ML |
| NEISSERIA CATARRHALIS | 150 M | ML |
| KLEBSIELLA PNEUMONIAE | 150 M | ML |
| HEMOPHILUS INFLUENZAE | 150 M | ML |